Emerson Electric Co. (EMR) Key Metrics
EMR valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $90.07B
- Enterprise value
- $97.31B
- P/E (TTM)
- 35.3 10-yr median 21.8
- Forward P/E
- 21.5
- PEG ratio
- 1.78
- Price / sales
- 4.9 10-yr median 3.0
- Price / book
- 4.2 10-yr median 4.6
- EV / EBITDA
- 18.6 10-yr median 13.9
- Dividend yield
- 1.37% $2.22 a year
- Beta
- 1.21
EMR key metrics, FY2016–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsEMR valuation Price multiples at each fiscal year-end price.
EMR returns How much profit the business earns on the capital it uses.
EMR per-share figures Results divided by the shares outstanding at year-end.
EMR financial health Debt, liquidity and how easily interest is covered.
EMR efficiency & capital use Working capital cycle and where the cash goes.
EMR valuation history
EMR returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
EMR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
EMR cash returned to shareholders
EMR price vs earnings per share
EMR key metrics
FY2016–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $74.34B | $62.78B | $55.75B | $43.41B | $56.69B | $39.77B | $41.49B | $48.65B | $40.43B | $35.26B |
| Enterprise value | $86.55B | $67.55B | $56.40B | $52.42B | $61.57B | $44.32B | $45.72B | $52.32B | $42.03B | $38.71B |
| P/E ratio | 32.4 | 31.9 | 4.2 | 13.4 | 24.6 | 20.2 | 18.0 | 22.1 | 26.6 | 21.6 |
| Price / sales | 4.1 | 3.6 | 3.7 | 3.1 | 4.4 | 2.4 | 2.3 | 2.8 | 2.6 | 2.4 |
| Price / book | 3.7 | 2.9 | 2.7 | 4.2 | 5.7 | 4.7 | 5.0 | 5.4 | 4.6 | 4.7 |
| Price / free cash flow | 27.9 | 21.6 | 203.5 | 18.2 | 18.9 | 15.6 | 17.2 | 21.4 | 28.2 | 14.5 |
| Price / operating cash flow | 24.0 | 18.8 | 87.5 | 14.9 | 15.9 | 12.9 | 13.8 | 16.8 | 21.1 | 12.2 |
| EV / sales | 4.8 | 3.9 | 3.7 | 3.8 | 4.8 | 2.6 | 2.5 | 3.0 | 2.8 | 2.7 |
| EV / EBITDA | 17.9 | 16.8 | 13.4 | 15.0 | 22.9 | 13.2 | 11.8 | 14.4 | 13.2 | 12.5 |
| EV / free cash flow | 32.5 | 23.2 | 205.9 | 21.9 | 20.6 | 17.4 | 19.0 | 23.0 | 29.3 | 15.9 |
| Earnings yield | 3.1% | 3.1% | 23.7% | 7.4% | 4.1% | 4.9% | 5.6% | 4.5% | 3.8% | 4.6% |
| Free cash flow yield | 3.6% | 4.6% | 0.5% | 5.5% | 5.3% | 6.4% | 5.8% | 4.7% | 3.6% | 6.9% |
| Dividend yield | 1.6% | 1.9% | 2.1% | 2.8% | 2.1% | 3.0% | 2.9% | 2.5% | 3.1% | 3.5% |
| Shareholder yield (dividends + buybacks) | 3.3% | 2.9% | 6.1% | 4.0% | 3.0% | 5.4% | 5.9% | 4.6% | 4.1% | 5.2% |
| Share price at fiscal year-end | $131.18 | $109.37 | $96.57 | $73.22 | $94.20 | $65.57 | $66.86 | $76.58 | $62.84 | $54.51 |
| Per share | ||||||||||
| Revenue per share | $31.79 | $30.47 | $26.27 | $23.28 | $21.49 | $27.67 | $29.60 | $27.40 | $23.72 | $22.45 |
| Earnings per share | $4.05 | $3.43 | $22.90 | $5.45 | $3.83 | $3.24 | $3.72 | $3.47 | $2.36 | $2.53 |
| Operating cash flow per share | $5.47 | $5.80 | $1.10 | $4.93 | $5.94 | $5.08 | $4.84 | $4.55 | $2.97 | $4.45 |
| Free cash flow per share | $4.71 | $5.07 | $0.47 | $4.03 | $4.98 | $4.20 | $3.89 | $3.58 | $2.23 | $3.76 |
| Cash per share | $2.72 | $6.25 | $13.95 | $3.04 | $3.91 | $5.46 | $2.41 | $1.72 | $4.76 | $4.92 |
| Book value per share | $35.79 | $37.69 | $35.84 | $17.48 | $16.42 | $13.86 | $13.27 | $14.08 | $13.55 | $11.70 |
| Tangible book value per share | −$13.00 | −$11.96 | −$0.09 | −$17.13 | −$1.19 | −$1.31 | −$1.48 | −$0.41 | $2.35 | $4.26 |
| Dividends per share | $2.10 | $2.09 | $2.08 | $2.06 | $2.01 | $1.99 | $1.95 | $1.93 | $1.93 | $1.90 |
| Capex per share | $0.76 | $0.73 | $0.63 | $0.90 | $0.97 | $0.89 | $0.96 | $0.97 | $0.74 | $0.69 |
| Debt per share | $24.28 | $14.56 | $15.08 | $18.24 | $12.02 | $12.96 | $9.22 | $7.49 | $7.24 | $10.26 |
| Shares outstanding | 566.7M | 574.0M | 577.3M | 592.9M | 601.8M | 606.6M | 620.6M | 635.3M | 643.4M | 646.8M |
| Change in shares outstanding | −1.3% | −0.6% | −2.6% | −1.5% | −0.8% | −2.3% | −2.3% | −1.3% | −0.5% | −4.4% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 10.9% | 9.3% | 85.1% | 31.9% | 25.2% | 23.6% | 26.8% | 24.9% | 18.6% | 20.9% |
| Return on invested capital (ROIC) | 9.1% | 8.9% | 10.6% | 10.7% | 11.4% | 18.7% | 20.3% | 21.5% | 18.1% | 16.6% |
| Return on assets (ROA) | 5.3% | 4.5% | 33.7% | 10.7% | 9.7% | 9.1% | 11.3% | 11.0% | 7.3% | 7.5% |
| Return on tangible assets | 16.0% | 12.5% | 60.1% | 21.3% | 16.3% | 14.4% | 20.3% | 19.7% | 12.3% | 9.7% |
| Free cash flow margin | 14.8% | 16.7% | 1.8% | 17.3% | 23.2% | 15.2% | 13.1% | 13.1% | 9.4% | 16.8% |
| Income quality (OCF / net income) | 1.35 | 1.69 | 0.05 | 0.90 | 1.55 | 1.57 | 1.30 | 1.31 | 1.26 | 1.76 |
| Financial health | ||||||||||
| Total debt | $13.76B | $8.36B | $8.71B | $10.81B | $7.23B | $7.86B | $5.72B | $4.76B | $4.66B | $6.63B |
| Cash & short-term investments | $1.54B | $3.59B | $8.05B | $1.80B | $2.35B | $3.31B | $1.49B | $1.09B | $3.06B | $3.18B |
| Net debt | $12.21B | $4.77B | $654.0M | $9.01B | $4.88B | $4.54B | $4.23B | $3.67B | $1.59B | $3.45B |
| Debt / equity | 0.68 | 0.39 | 0.42 | 1.04 | 0.73 | 0.94 | 0.69 | 0.53 | 0.53 | 0.88 |
| Debt / assets | 0.33 | 0.19 | 0.20 | 0.30 | 0.29 | 0.34 | 0.28 | 0.23 | 0.24 | 0.31 |
| Net debt / EBITDA | 2.52 | 1.18 | 0.16 | 2.57 | 1.81 | 1.35 | 1.09 | 1.01 | 0.50 | 1.11 |
| Current ratio | 0.88 | 1.77 | 2.75 | 1.09 | 1.35 | 1.52 | 1.19 | 1.07 | 1.64 | 1.24 |
| Quick ratio | 0.65 | 1.40 | 2.35 | 0.87 | 1.02 | 1.19 | 0.88 | 0.78 | 1.30 | 1.09 |
| Interest coverage | 9.1 | 8.3 | 10.6 | 10.3 | 11.8 | 15.9 | 15.5 | 14.6 | 13.4 | 12.6 |
| Working capital | −$1.21B | $4.45B | $8.79B | $729.0M | $2.19B | $3.02B | $1.16B | $455.0M | $3.21B | $1.95B |
| Invested capital | $32.50B | $26.40B | $21.34B | $19.37B | $14.76B | $12.95B | $12.46B | $12.61B | $10.31B | $11.02B |
| Tangible asset value | −$7.35B | −$994.0M | $5.86B | −$4.20B | −$677.0M | −$755.0M | −$878.0M | −$216.0M | $1.56B | $2.81B |
| Net current asset value | −$13.08B | −$6.54B | −$2.33B | −$10.85B | −$6.36B | −$5.63B | −$5.08B | −$4.78B | −$2.57B | −$4.17B |
| Graham number | $57.08 | $53.92 | $135.88 | $46.30 | $37.60 | $31.78 | $33.30 | $33.15 | $26.82 | $25.80 |
| Graham net-net per share | −$29.45 | −$17.18 | −$9.02 | −$25.27 | −$15.26 | −$13.28 | −$12.17 | −$11.23 | −$7.16 | −$12.85 |
| Capital allocation | ||||||||||
| Dividends paid | $1.19B | $1.20B | $1.20B | $1.22B | $1.21B | $1.21B | $1.21B | $1.23B | $1.24B | $1.23B |
| Share buybacks (net) | $1.24B | $643.0M | $2.21B | $500.0M | $500.0M | $942.0M | $1.25B | $1.00B | $400.0M | $601.0M |
| Dividend payout ratio | 52.0% | 61.0% | 9.1% | 37.9% | 52.5% | 61.5% | 52.4% | 55.8% | 81.6% | 75.0% |
| Dividends + buybacks / free cash flow | 91.3% | 63.3% | — | 72.1% | 57.1% | 84.5% | 101.9% | 98.0% | 114.1% | 75.1% |
| Capex / revenue | 2.4% | 2.4% | 2.4% | 3.8% | 4.5% | 3.2% | 3.2% | 3.5% | 3.1% | 3.1% |
| Capex / operating cash flow | 13.9% | 12.6% | 57.0% | 18.2% | 16.3% | 17.5% | 19.8% | 21.3% | 24.9% | 15.5% |
| Capex / depreciation | 0.28 | 0.25 | 0.35 | 0.51 | 0.60 | 0.63 | 0.72 | 0.81 | 0.75 | 0.79 |
| Stock-based compensation / revenue | 1.5% | 1.5% | 1.6% | 1.0% | 1.7% | 0.7% | 0.7% | 1.2% | 0.7% | 1.0% |
| R&D / revenue | — | 4.5% | 3.4% | 2.8% | 3.8% | 2.6% | 2.5% | 2.5% | 2.2% | 2.2% |
| SG&A / revenue | 28.3% | 29.4% | 27.6% | 26.2% | 27.0% | 23.7% | 24.3% | 24.5% | 23.6% | 23.9% |
| Efficiency | ||||||||||
| Days sales outstanding | 61.1 | 56.8 | 57.5 | 69.2 | 81.5 | 62.9 | 59.7 | 63.9 | 69.0 | 70.0 |
| Days of inventory on hand | 94.4 | 88.8 | 88.4 | 92.3 | 100.8 | 71.1 | 63.8 | 64.2 | 60.0 | 67.5 |
| Days payables outstanding | 58.4 | 55.3 | 60.2 | 82.4 | 96.9 | 67.0 | 66.0 | 68.0 | 68.0 | 67.5 |
| Cash conversion cycle (days) | 97.0 | 90.2 | 85.7 | 79.1 | 85.4 | 67.0 | 57.5 | 60.1 | 61.0 | 70.0 |
| Receivables turnover | 5.98 | 6.42 | 6.35 | 5.28 | 4.48 | 5.80 | 6.12 | 5.71 | 5.29 | 5.21 |
| Payables turnover | 6.25 | 6.60 | 6.07 | 4.43 | 3.77 | 5.45 | 5.53 | 5.36 | 5.36 | 5.41 |
| Inventory turnover | 3.87 | 4.11 | 4.13 | 3.95 | 3.62 | 5.13 | 5.72 | 5.69 | 6.08 | 5.41 |
| Asset turnover | 0.42 | 0.40 | 0.39 | 0.46 | 0.54 | 0.77 | 0.90 | 0.87 | 0.74 | 0.66 |
| Average receivables | $3.01B | $2.72B | $2.39B | $2.62B | $2.89B | $2.89B | $3.00B | $3.05B | $2.89B | $2.79B |
| Average payables | $1.36B | $1.30B | $1.28B | $1.69B | $1.91B | $1.79B | $1.91B | $1.86B | $1.65B | $1.53B |
| Average inventory | $2.20B | $2.09B | $1.87B | $1.90B | $1.99B | $1.90B | $1.85B | $1.75B | $1.45B | $1.53B |
| Intangibles / total assets | 65.9% | 64.4% | 48.5% | 57.5% | 42.9% | 40.2% | 44.6% | 45.1% | 36.8% | 22.1% |
Computed from EMR's annual financial statements (latest annual report filed November 10, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
EMR valuation and financial ratios
At the end of fiscal 2025 (September 30, 2025), Emerson traded at 32.4 times earnings, against a 10-year median of 21.8. Based on the latest twelve months, the trailing P/E is 35.3 and the forward P/E is 21.5. Emerson earned a return on equity of 10.9% and a return on invested capital of 9.1% in fiscal 2025. It ended the year with $13.8 billion of debt and $1.5 billion in cash and short-term investments, net debt of $12.2 billion. It returned $2.4 billion to shareholders: $1.2 billion in dividends and $1.2 billion in share buybacks, 91% of free cash flow. The share count fell 12.4% from 646.8M to 566.7M over 9 years.
See the EMR income statement, the EMR chart for price history, or the EMR stock overview for the latest quote and news.
EMR key metrics FAQ
What is Emerson's P/E ratio?
Emerson's trailing P/E ratio is 35.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 21.5. At the end of fiscal 2025 it was 32.4, compared with a 10-year median of 21.8.
What is Emerson's EV/EBITDA?
Emerson's enterprise value was 17.9 times EBITDA at the end of fiscal 2025 (enterprise value $86.6 billion, EBITDA $4.8 billion); the current EV/EBITDA is 18.6.
What is Emerson's return on equity?
Emerson's return on equity (ROE) was 10.9% in fiscal 2025: net income of $2.3 billion on average shareholders' equity of $21.0 billion.
What is Emerson's ROIC?
Emerson's return on invested capital was 9.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Emerson have?
Emerson had total debt of $13.8 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.68 and $12.2 billion of net debt (2.52 times EBITDA).
What is Emerson's dividend yield?
Emerson's forward dividend yield is 1.37%. Emerson paid $1.2 billion in dividends in fiscal 2025 ($2.10 per share), a payout ratio of 52.0%.
Does Emerson buy back its shares?
Yes. Emerson spent $1.2 billion on net share repurchases in fiscal 2025 Shares outstanding changed −1.3% over the year, to 566.7M..
What is Emerson's free cash flow yield?
Emerson generated $2.7 billion of free cash flow in fiscal 2025, a free cash flow yield of 3.6% on its market value at year-end ($74.3 billion).
What is Emerson's current ratio?
Emerson's current ratio was 0.88 at the end of fiscal 2025: current assets were 0.88 times current liabilities.